Saber-sheath trachea

From WikiMD's WELLNESSPEDIA

Saber-sheath trachea is a medical condition characterized by a marked coronal narrowing and sagittal widening of the trachea. This condition is often associated with COPD, particularly in long-term smokers. The name "saber-sheath" is derived from the appearance of the trachea, which resembles the sheath of a saber due to its narrowed and elongated shape.

Symptoms[edit]

Patients with saber-sheath trachea may experience symptoms such as dyspnea (shortness of breath), cough, and recurrent respiratory infections. However, these symptoms are not specific to saber-sheath trachea and can be seen in various other respiratory conditions.

Diagnosis[edit]

The diagnosis of saber-sheath trachea is typically made through imaging studies. A CT scan of the chest can reveal the characteristic shape of the trachea. In some cases, a bronchoscopic examination may be performed to confirm the diagnosis.

Treatment[edit]

The treatment of saber-sheath trachea primarily involves managing the underlying COPD. This may include medications to control symptoms, pulmonary rehabilitation, and in severe cases, lung transplantation. In some cases, surgical intervention may be required to correct the shape of the trachea.

Prognosis[edit]

The prognosis of saber-sheath trachea is largely dependent on the severity of the underlying COPD. With appropriate management, the symptoms of saber-sheath trachea can be controlled and the progression of the disease can be slowed.

See also[edit]



References[edit]


External links[edit]






Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.